Suppr超能文献

脊髓灰质炎病毒在培养细胞中复制不需要CD44,且CD44不限制其在单核细胞中的复制。

CD44 is not required for poliovirus replication in cultured cells and does not limit replication in monocytes.

作者信息

Freistadt M S, Eberle K E

机构信息

Department of Microbiology, Immunology and Parasitology, Louisiane State University Medical Center, New Orleans 70112, USA.

出版信息

Virology. 1996 Oct 15;224(2):542-7. doi: 10.1006/viro.1996.0561.

Abstract

Although poliovirus receptor is required to mediate poliovirus infection, its role in mediating the tissue specificity of poliovirus replication in natural infections remains unclear due to the presence of this receptor in nonsusceptible cells. It has been hypothesized that CD44 has a role in determining the susceptibility of cell to poliovirus. To test this hypothesis, we determined whether HepG2, a cultured cell line that lacks cell surface CD44, can support poliovirus replication. We found that PV(1) Mahoney, PV(2)W2, and PV(3)Leon strains of poliovirus can replicate in HepG2 cells. Jurkat cells, which also lack CD44, support PV replication. These results suggest that CD44 is not required for poliovirus replication in cultured cells. To examine this question further expression of CD44 in primary human monocytes was examined. Greater than 90% of monocytes express the poliovirus receptor but only 6% of these cells are susceptible to poliovirus infection, making this a good system to study blocks to poliovirus replication. 97% of primary human monocytes reacted with a monoclonal antibody against CD44 that has been shown to block poliovirus binding and replication. This finding suggests that CD44 is present on more cells that poliovirus infects, making CD44 unlikely to be the factor limiting poliovirus replication in human tissues.

摘要

尽管脊髓灰质炎病毒感染需要脊髓灰质炎病毒受体介导,但由于该受体存在于非易感细胞中,其在介导脊髓灰质炎病毒自然感染中复制的组织特异性方面的作用仍不清楚。据推测,CD44在决定细胞对脊髓灰质炎病毒的易感性方面起作用。为了验证这一假设,我们确定缺乏细胞表面CD44的培养细胞系HepG2是否能支持脊髓灰质炎病毒复制。我们发现脊髓灰质炎病毒的PV(1)Mahoney、PV(2)W2和PV(3)Leon毒株能在HepG2细胞中复制。同样缺乏CD44的Jurkat细胞也支持脊髓灰质炎病毒复制。这些结果表明,在培养细胞中脊髓灰质炎病毒复制不需要CD44。为了进一步研究这个问题,我们检测了原代人单核细胞中CD44的表达情况。超过90%的单核细胞表达脊髓灰质炎病毒受体,但其中只有6%的细胞对脊髓灰质炎病毒感染易感,这使其成为研究脊髓灰质炎病毒复制阻断的良好系统。97%的原代人单核细胞与一种抗CD44单克隆抗体发生反应,该抗体已被证明可阻断脊髓灰质炎病毒的结合与复制。这一发现表明,脊髓灰质炎病毒感染的细胞中存在CD44的细胞更多,这使得CD44不太可能是限制脊髓灰质炎病毒在人体组织中复制的因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验